This synopsis summarizes set of guidelines that used recent clinical trials data in the development of updated guidelines for management of the regional node basin for 2 groups of patients: those with newly diagnosed, invasive melanoma and a clinically negative node basin and those found to be sentinel node positive.1 Several pivotal clinical trials have shaped the understanding of the importance of the regional node status and altered the clinical approach to the regional node basin.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Lange JR. Review of the Guidelines on the Management of the Regional Lymph Nodes in Patients With Melanoma. JAMA Surg. Published online January 08, 2020. doi:10.1001/jamasurg.2019.5417
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: